5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The farnesyl transferase inhibitor SCH 66336 induces regression of Hras-driven tumors in mice with widespread endogenous expression of HrasG12V
    Meeting Abstract

    Chen, X.; Johnson, L. K.; Knauf, J. A.; Fagin, J. A.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Identification of PHLPP as a tumour suppressor reveals the role of pathway feedback compensation in PTEN-mutant prostate cancer progression
    Meeting Abstract

    Chen, M. H.; Pratt, C. P.; Zeeman, M. E.; Schultz, N.; Taylor, B. S.; O'Neill, A.; Castillo-Martin, M.; Nowak, D. G.; Naguib, A.; Grace, D. M.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • A phase II trial of ganetespib: Efficacy and safety in patients (pts) with metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Drullinsky, P.; Sugarman, S.; Wasserheit-Leiblich, C.; Moynahan, M. E.; D'Andrea, G.; Haque, S.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • The AR axis as a pathogenetic mechanism and therapeutic target throughout the clinical states of prostate cancer: Opportunities for second-line hormonal manipulations in castration-resistant prostate cancer
    Book Section

    Mitsiades, N.; Chen, Y.; Scher, H. I.
    In Scardino, P. T.; Linehan, W. M.; Zelefsky, M. J.; Vogelzang, N. J.; Sheinfeld, J.; Rini, B. I.; Bochner, B. H. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 4th ed (2011)

    Fulltext@MSK | Save
  • Androgen receptor signaling in castration-resistant prostate cancer
    Book Section

    Carver, B. S.; Sawyers, C. L.
    In Scardino, P. T.; Linehan, W. M.; Zelefsky, M. J.; Vogelzang, N. J.; Sheinfeld, J.; Rini, B. I.; Bochner, B. H. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 4th ed (2011)

    Fulltext@MSK | Save
  • Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
    Journal Article

    Tefferi, A.; Abdel-Wahab, O.; Ervantes, F. C.; Crispino, J. D.; Finazzi, G.; Girodon, F.; Gisslinger, H.; Gotlib, J.; Kiladjian, J. J.; Levine, R. L.; more...
    Blood Cancer Journal (2011)

    Fulltext@MSK | Save
  • Induction of megakaryocyte polyploidization in combination with JAK inhibition as a novel therapeutic strategy for myeloproliferative neoplasms
    Meeting Abstract

    Wen, Q. J.; Goldenson, B.; Malinge, S.; Koppikar, P.; Levine, R. L.; Tefferi, A.; Crispino, J.
    Blood (2011)

    Fulltext@MSK | Save
  • HSP90 inhibition targets JAK2 and is highly effective in CRLF2-rearranged acute lymphoblastic leukemia
    Meeting Abstract

    Weigert, O.; Bird, L.; Kopp, N.; Lane, A. A.; Chapuy, B.; van Bodegom, D.; Marubayashi, S.; Yoda, A.; Romanet, V.; Murakami, M.; more...
    Blood (2011)

    Fulltext@MSK | Save